3 Comments

  1. John Mammoser
    April 26, 2015 @ 10:12 am

    SIHGLE PAYER,NKW

    Reply

  2. Edward E Sharp II
    April 26, 2015 @ 12:56 pm

    Medicare D should be amended to require competitive bidding by pharmaceuticals, distributors, and direct sellers.

    Reply

  3. Lois Keel
    April 26, 2015 @ 11:26 pm

    Sounds like good policy at the federal level.
    Don’t have a problem with pharmaceutical companies getting a reasonable return for their products, but many of the existing companies have been fined large amounts multiple times for sleazy practices.
    Millions of people’s health & lives depend on reasonable access to medications, while drug companies play profitable games with the drugs.

    Reply

Leave a Reply

Your email address will not be published.